Effect of Endoplasmic Reticulum Stress on Metabolic Function.

Trial Profile

Effect of Endoplasmic Reticulum Stress on Metabolic Function.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 May 2015

At a glance

  • Drugs Sodium phenylbutyrate (Primary) ; Tauroursodeoxycholic acid (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 29 Apr 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 09 Dec 2013 Planned end Ddte changed from 1 Sep 2011 to 1 Dec 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top